Mangrove Partners Cortexyme, Inc. Transaction History
Mangrove Partners
- $637 Million
- Q1 2025
A detailed history of Mangrove Partners transactions in Cortexyme, Inc. stock. As of the latest transaction made, Mangrove Partners holds 11,000 shares of CRTX stock, worth $14,190. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,000Holding current value
$14,190% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding CRTX
# of Institutions
42Shares Held
5.9MCall Options Held
92.6KPut Options Held
3.1K-
Vanguard Group Inc Valley Forge, PA1.29MShares$1.66 Million0.0% of portfolio
-
Epiq Capital Group, LLC San Francisco, CA825KShares$1.06 Million0.31% of portfolio
-
Ieq Capital, LLC807KShares$1.04 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny500KShares$644,8800.0% of portfolio
-
Geode Capital Management, LLC Boston, MA396KShares$510,4650.0% of portfolio
About Cortexyme, Inc.
- Ticker CRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,150,800
- Market Cap $70.5M